Dermatology Biologics - FOI Response Register

FoI Number
2025-084
Subject
Dermatology Biologics
Date Received
05/05/2025
Request and Response
  1. How many patients were treated in the last 3 months by the Dermatology department (for any medical condition) with the following biologic drugs:

NHS Shetland does not have a Dermatology Department

 

•           Adalimumab - Humira

•           Adalimumab Biosimilar

•           Apremilast

•           Bimekizumab

•           Brodalumab

•           Certolizumab

•           Deucravacitinib

•           Dimethyl fumarate

•           Etanercept - Enbrel

•           Etanercept Biosimilar

•           Guselkumab

•           Infliximab - Remicade

•           Infliximab Biosimilar

•           Ixekizumab

•           Risankizumab

•           Secukinumab

•           Tildrakizumab

•           Ustekinumab - Stelara

•           Ustekinumab Biosimilar

•           Spesolimab